Since the outbreak of COVID-19, the pharma industry has moved with unprecedented speed to progress vaccines through clinical trials safely, while simultaneously ramping up production on the chance of success.
As the world awaits news from these expedited clinical trials, however, we must also acknowledge that the task of vaccinating the world against COVID-19 won’t be easy – especially when it comes to bringing the public on side.
This paper uses Ipsos research to highlight the obstacles and opportunities that lie ahead – and the importance of building public support in determining any vaccine’s success.
Global vaccines research
As the race to vaccinate the global population gathers speed, the world continues to face many more questions than answers – not only about how long the vaccination process will take, but how it will roll out, willingness to have the vaccine, and once vaccinations have become widespread, how the journey continues back to ‘normal’…?